Comments

DiaMedica Therapeutics

DMACNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$4.49
0.368.72%
Pre-Market: Sep 16, 5:54 PM EDT
15 minutes delayed
DiaMedica Therapeutics (DMAC) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

DiaMedica Therapeutics (NASDAQ:DMAC) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for DiaMedica Therapeutics (DMAC)?

A

There have been no specific sales or earnings guidance reported for DiaMedica Therapeutics in recent months.

Browse guidance and forecast on all stocks.